Kaizhong Wang1,2
Xiangyan Liu1,2
Huagui Huang1,2
Moran Suo1,2
Jinzuo Wang1,2
Xin Liu1,2
Jing Zhang1,2
Xin Chen3
Zhonghai Li1,2,4*- 1Department of Orthopedics, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China
- 2Key Laboratory of Molecular Mechanism for Repair and Remodeling of Orthopedic Diseases, Dalian, Liaoning, China
- 3Musculoskeletal Research Laboratory, Department of Orthopedics & Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
- 4Dalian Innovation Institute of Stem Cell and Precision Medicine, Dalian, Liaoning, China
Intervertebral disk degeneration (IDD) is a common clinical spinal disease and one of the main causes of low back pain (LBP). Generally speaking, IDD is considered a natural degenerative process with age. However, with the deepening of research, people have discovered that IDD is not only related to age, but also has many factors that can induce and accelerate its progression. In addition, the pathogenesis of IDD remains unclear, resulting in limited traditional treatment methods that cannot effectively prevent and treat IDD. Conservative treatment may lead to patients’ dependence on drugs, and the pain relief effect is not obvious. Similarly, surgical treatment is highly invasive, with a longer recovery time and a higher recurrence rate. With the deepening of exploration, people have discovered that intestinal microorganisms are an important symbiotic microbial community in the human body and are closely related to the occurrence and development of various diseases. Changes in intestinal microorganisms and their metabolites may affect the body’s inflammatory response, immune regulation, and metabolic processes, thereby affecting the health of the intervertebral disk. In this context, the gut microbiota has received considerable attention as a potential target for delaying or treating IDD. This article first introduces the impact of gut microbes on common distal organs, and then focuses on three potential mechanisms by which gut microbes and their metabolites influence IDD. Finally, we also summarized the methods of delaying or treating IDD by interfering with intestinal microorganisms and their metabolites. Further understanding of the potential mechanisms between intestinal microorganisms and IDD will help to formulate reasonable IDD treatment strategies to achieve ideal therapeutic effects.
1 Introduction
LBP is a very common symptom worldwide. It occurs at various economic levels in countries and people of all ages, ranging from children to the elderly population, and lumbago is the main cause of global disability. As the population ages, LBP in our country has become a social public health problem, causing serious economic burdens on people’s lives and society (Yao et al., 2011; Buchbinder et al., 2018; Hartvigsen et al., 2018; Wu et al., 2020). The incidence of LBP caused by disk degeneration is 40%, and disk degeneration is considered the main cause of LBP (Yao et al., 2011). Although IDD has been intensively studied, the exact pathophysiology is poorly understood. Known etiologies of IDD include aging, cytoreduction, and altered ECM composition, which cause disrupted homeostasis, as well as changes in IDD function and structure (Vergroesen et al., 2015). Moreover, external factors such as smoking, trauma, obesity, nutritional and metabolic disorders, abnormal mechanical loading, environment and genetics can also lead to IDD through the induction of inflammation, apoptosis, proinflammatory cytokine secretion and autophagy (Risbud and Shapiro, 2014; Vo et al., 2016; Ohnishi et al., 2022).
Because the mechanism of disk degeneration is not clear, current IDD treatments can only relieve the patient’s symptoms with drugs or surgery. Conservative treatment may result in patient dependence on medications and inadequate pain relief. Similarly, surgical treatment is highly invasive and often requires a longer postoperative recovery time, as well as a high recurrence rate (Fan et al., 2023). This requires new treatment guidance. With the study of IDD pathogenesis and influencing factors, people have gradually found that gut microbes and many closely related organs, and use “axis” to represent the relationship between the intestinal tract, microorganisms and other organs, such as the “gut-bone axis” (Kohgo, 2001), “gut-brain axis” (Travagli and Rogers, 2001), and “gut-liver axis” (Zeuzem, 2000). Rajasekaran (Rajasekaran et al., 2020) and others found that there was microbial overlap between gut microbes and the intervertebral disk and that changes in gut microbes had a subtle impact on the degeneration of the intervertebral disk. The intestinal bacterial genera associated with IDD include Family Rikenellaceae, id.967, Family Ruminococcaceae, id.2050, Genus Escherichia Shigella, id.3504, Genus Eubacterium coprostanoligenes group, id.11375, Genus Gordonibacter, id.821, Genus Lachnoclostridium, id.11308, Genus Oscillospira, id.2064, Phylum Bacteroidetes, id.905, etc (Geng et al., 2023). The concept of the “gut-intervertebral disk axis” was also proposed in Li et al. (2022). This review summarizes the effects of gut microbes on disk degeneration and summarizes the progress of several studies.
2 Structure of the IVD
The IVD is an avascular tissue that receives only small arteries that supply the outermost fibers of the AF and is composed of fibrous tissue and cartilage (Boxberger et al., 2009; Mohd Isa et al., 2022). Its main function is to transfer compressible loads between vertebrae while providing flexibility (Dowdell et al., 2017). Normal anatomy underlies the physiological function of the IVD (Lin et al., 2023). The intervertebral disk (IVD) is a strong, flexible structure found between neighboring vertebrae and consists of the nucleus pulposus (NP), annulus fibrosus (AF), and cartilage endplate (CEP) (Colombini et al., 2008).
The AF is a ring of fibers composed of highly organized 15 to 25 concentric collagen fiber layers called sheets that surround the NP. Each sheet is formed from tough collagen fibers tilted approximately 30° from one vertebra to another (Mohd Isa et al., 2022). The fibers of adjacent sheets cross each other in opposite directions at an angle of more than 60. This arrangement allows for limited rotation and bending between adjacent vertebrae and enables the IVD to withstand the circumferential load (Molladavoodi et al., 2020; Mohd Isa et al., 2022). The NP is the core of the IVD. Between 70% and 90% of its dry weight is composed of water, with 35–65% proteoglycan, 5–20% thin type II collagen fibers, and the remaining noncollagen and elastin. Proteoglycan retains the high water content of the NP and is hydraulically distributed to the ECM to reduce the stress of the IVD (Lv et al., 2014). CEP is a hyaline cartilage buffer composed of round cells located between the vertebral endplate and NP. It acts as a physical barrier and a conduit for supplying nutrients to the intervertebral disk (Moon et al., 2013). The CEP consists of approximately 60% water, and the main dry weight components are type II. collagen and proteoglycans (Newell et al., 2017). Morphologically, CEP contains elongated cells parallel to the IVD that are aligned with collagen fibers, and the cells produce a collagen-rich transmembrane matrix and a proteoglycan-rich regional matrix (Lakstins et al., 2021).
3 Factors influencing IDD
The induction and progression of IDD is a complex process that is usually affected by multiple factors such as age, genetics, non-physiological mechanical loading, obesity, and nutritional disorders. Under the combined effect of these factors, many pathological changes occur, such as inflammation, ECM degradation, oxidative stress, mitochondrial dysfunction, IVD cell destruction, loss of physiological cell function, ECM metabolic disorder, NP fibrosis, AF disintegration and CEP calcification. This ultimately leads to the reduction of IVD mechanical properties, IVD height, and NP size, leading to the emergence and development of IDD.(Guo et al., 2022; Xu et al., 2023; Figure 1).
Figure 1. The IVD is affected by many factors (age, mechanical load, obesity, gut microorganisms, nutritional disorders, transmission, nutritional disorders, etc.) and undergoes a series of pathological changes (cell loss, inflammation, extracellular matrix degradation, NP fibrosis, vascular, neural proliferation, CEP calcification, AF disruption, oxidative stress, etc.) leading to IDD. Abbreviations: IVD, intervertebral disk; IDD, intervertebral disk degeneration; NP, nucleus pulposus; CEP, cartilage endplate; AF, annulus fibrosus.
Research has indicated that cellular senescence increases with age, featuring permanent cessation of the cell cycle and a senescence-linked secretory phenotype (SASP). Senescent cells (SCs) that release SASP products produce numerous substances, including inflammatory cytokines, growth regulators, chemokines, angiogenic factors, and matrix metalloproteinases (MMPs)(Gorgoulis et al., 2019; Patil et al., 2019; Xu et al., 2023). The expression and activity of MMP subgroups in IVD are significantly enhanced. Due to their important role in ECM deterioration and remodeling, the expression and activity of MMP subgroups in IVD are significantly enhanced, leading to the destruction of ECM balance and induction of IDD (Zou X. et al., 2023). Moreover, the SASP produced by the SCs in the IVD can disrupt the metabolic balance in the ECM, leading to an imbalance of the IVD in vitro and in vivo and inducing the development of IDD (Wu et al., 2022; Xu et al., 2023). In addition, mitochondrial dysfunction and oxidative stress often occur in aging organisms and can cause mitochondrial autophagy and NP cell apoptosis, thus leading to IDD (Xu et al., 2019).
In addition to age, researchers have found a relationship between IDD and genetics, and many of the genes were identified as having a single nucleotide polymorphism (SNP) that affects the risk of developing IDD (Martirosyan et al., 2016; Dickinson and Bannasch, 2020). Prolonged compression, strain, and acute nonphysiological loading all lead to a series of changes in the IVD, such as tissue damage, reduced vascular sprouting, reduced cell activity, inflammatory factor release, and ECM degradation, ultimately leading to IDD (Zhan et al., 2020; Zhan et al., 2021; Zhou Z. et al., 2021). Because the IVD lacks a blood supply, the IVD is a hypoxic, low-nutrient acidic microenvironment (McDonnell et al., 2023). In this environment, it leads to cell death, decreased metabolic activity, and activation of autophagy, for example, in AF cells (Yurube et al., 2019). In addition, these factors can also lead to the activation and enhancement of autophagic activity within the IVD, especially in NP cells, which eventually leads to the development and progression of IDD (Kritschil et al., 2022). In addition, a two-sample Mendelian randomization study revealed that IDD is closely linked to body mass index (BMI), and when a person is obese, the risk of IDD greatly increases (Zhou J. et al., 2021). The poor blood supply of the IVD and the poor ability to repair itself, when affected by the above pathological or physiological factors, can induce IDD or accelerate IDD development.
4 The role of the GM in the human body
Microorganisms inhabit all the surfaces of the human body, but large numbers of them live in the gastrointestinal tract. The human gut harbors approximately one thousand microbial species that form a complex ecological community called the gut microbiota (Lagier et al., 2016). The gut microbiome has recently been classified as a “vital organ”. It not only plays an important role in maintaining the homeostasis of the intestinal ecosystem and intestinal nutrient absorption, but also interacts with the host immune system, enhances immune response, defends against pathogens, and helps maintain the intestinal barrier function to prevent harmful substances from entering the blood. Participate in the metabolism of fats, sugars, and proteins. Certain intestinal microorganisms are able to synthesize vitamins (such as vitamin K and some B vitamins), which are essential for maintaining health. The composition of each person’s intestinal microorganisms is unique and is influenced by multiple factors such as genetics, diet, and environment. This difference may affect health status and susceptibility to disease (Gomes et al., 2018; Yuan et al., 2021). Communicate with other organs by forming interconnected “axis”-like pathways Any change in the microbial community not only leads to gut-related problems but also affects other organ-related diseases, although the actual mechanisms of interaction between the gut and organs are not yet fully understood (Afzaal et al., 2022). Typical progressive studies of intestinal microgrowth on other organs include studies on the intestinal-bone axis, intestinal-brain axis, and intestinal-liver axis (Figure 2 and Table 1).
Figure 2. Gut microorganisms and various distal organs constitute a pathway of influence, which we call axes, such as the gut-bone axis, the gut-brain axis, and the gut-hepatic axis. Gut microorganisms, under the influence of stress response, inflammation, immunity, etc., produce a variety of inflammatory mediators, such as IL-1, IL-6, and tumor necrosis factor, and a variety of immune cells, such as B cells, T cells, and monocytes, as well as the metabolites SCFA and LPS, which arrive at distal organs through the blood circulation and are involved in disease progression. IL-1, interleukin 1; IL-6, interleukin 6; SCFA, short-chain fatty acid; LPS, lipopolysaccharide.
Table 1. Studies related to the effects of gut microbes on bone, brain and liver.
4.1 Gut-bone axis
The gut microbiota plays a key role in bone formation and development (Seely et al., 2021). Calcium is a key nutrient essential for bone health, and calcium deficiency can cause osteopenia in individuals with osteoporosis (Chen et al., 2022). Gut microbes play an important role in the homeostasis of bone (Behera et al., 2020). Raveschot et al. reported that probiotic supplements (Lactobacillus strains) are beneficial for the transport and uptake of calcium in mice. Probiotics are defined as “living microorganisms”, which proves the importance of calcium absorption by microorganisms for bone development (Holick, 2007; Behera et al., 2020). Vitamin D has a very significant impact on the absorption of calcium and phosphorus and on bone metabolism in the human body, and Zu et al. reported that an imbalance of the intestinal flora limits the production of vitamin D (Holick, 2007; Zuo et al., 2019). Bora et al. (2018) used mice with microorganisms and not microbiota to observe the ability of vitamin D to regulate calcium metabolism and found that the levels of 1,25-dihydrooxygen vitamin D and calcium were restored in microbial mice. In addition, Zaiss et al. (2019) A dynamic study revealed that SCFAs, one of the major metabolites of gut microorganisms, can blunt osteoclast-mediated inhibition of histone deacetylase (HDAC) activity; thus, osteoclast differentiation prevents the prevention of bone loss, and it was also found that dietary supplementation with SCFAs, which generate oligosaccharides, can increase bone mineral density (BMD), thus affecting bone development. Lin et al. (2023) showed that ovariectomized mice fed B. vulgatus exhibited increased bone resorption and poor bone microstructure, whereas mice fed serum valeric acid (VA) showed decreased bone resorption and improved bone microstructure. VA inhibits RELA protein production (proinflammatory) and enhances IL-10 mRNA expression (anti-inflammatory), resulting in the inhibition of osteoclast-like cell maturation and enhanced osteoblast maturation in vitro.
Furthermore, Li et al. (2023) in an ovariectomy (OVX) mouse model, OVX induced a surprising disruption of the microbial community, leading to intestinal leakage, intestinal barrier dysfunction and the aggravation of postmenopausal osteoporosis (PMO). Additionally, lipopolysaccharide (LPS)-triggered inflammatory cytokines released from the intestine to the bone marrow were found to be associated with bone loss in ovariectomized (OVX) mice. Long-term dietary isisquercetin was used. The microbial community and gut barrier function improved in OVX mice. Thus, the inhibition of the NF-KB signaling pathway significantly improved bone loss and the host inflammatory status, and isoquercetin treatment dose-dependently inhibited the inflammation induced by LPS. In addition, it partially promoted the proliferation and differentiation of osteoblasts. These advances were all conducted through the gut-bone axis while reflecting the influence of gut microorganisms on bone physiopathology through multiple pathways in the intestinal-bone axis.
4.2 Gut-brain axis
Mounting evidence indicates that fluctuations in the gut microbiome can affect brain function and behavior. It was once believed that cognition was solely controlled by the central nervous system. However, it is now becoming clear that many nonneurological factors, including gut-resident bacteria of the gastrointestinal tract, regulate and influence cognitive dysfunction and processes as well as neurodegenerative and cerebrovascular diseases (Zhu et al., 2020).
In the study of Zou et al. cerebrovascular disease (CeVD) has high morbidity, mortality, and disability, posing a serious threat to human health (Zou et al., 2022). Gut bacteria significantly affect the onset, progression, and prognosis of CeVD. The gut microbiota plays a key role in gut–brain interactions, and the gut–brain axis is critical for CeVD communication. Olanzapine (OLZ) is a representative atypical antipsychotic (AAPC) prone to cause weight gain, obesity, hyperglycemia and dyslipidemia after long-term use (Visconti et al., 2019). Zhu Z. et al. (2022) studied the side effects of olanzapine-induced lipid metabolism disorders and reported that olanzapine increased the Firmicutes/Bacteroidetes (F/B) ratio and reduced the abundance of serotonin (5-HAT). SCFAS, one of the main metabolites of intestinal microbes, was proven to promote the secretion of 5-HT by stimulating receptors on vagal nerve 3 vagal nerve endings via 5-HT, thus regulating the body’s lipid metabolism (Browning, 2015). The vagus nerve is a physiological link between gut microbes and the central nervous system and regulates the host appetite by transmitting gut hormone signals secreted by the gut (Cork, 2018). After receiving signals that involve serotonin from the gut, the brain controls hunger by producing the neuropeptide Y/rat-related peptide (NPY/AgRP) in the hypothalamus. By acting as appetite stimulants, NPY and AgRP can prompt eating and decrease the amount of energy used (Schwartz et al., 2000; Savontaus et al., 2002). This study also demonstrated a link between gut microbes and the brain.
In addition, Zhu R. et al. (2023) reported that the intestinal microflora in Alzheimer’s disease (AD) patients decreased, the intestinal flora of AD mice improved in response to probiotics, and the AD symptoms improved. Zhu H. et al. (2022) reported that perinatal transmission of probiotic Bifidobacterium strains prevented emotional and gastrointestinal motility disorders caused by stress early in life. Zou L. et al. (2023) reported that a diet high in cholesterol also promoted anxiety and depression in mice by affecting gut microbes. According to the above studies, there is an interconnection between the intestinal microbiome and the brain, and many related mechanisms of disease occurrence and progression are achieved through the gut-brain axis.
4.3 Gut-liver axis
Marshall introduced the idea of the “liver-gut” axis in 1998, sparking increased interest in the connection between the gut and liver. The liver is greatly impacted by changes in the intestinal flora as intestinal bacteria or their byproducts travel to the liver through the portal vein. Understanding the liver-gut axis is crucial for understanding the pathophysiology of various liver diseases, such as nonalcoholic fatty liver disease and hepatic encephalopathy (Minemura and Shimizu, 2015; Hrncir et al., 2019; Guo et al., 2022; Zucoloto et al., 2023).
Through this research, Chassaing et al. (2014) found that changes in the gut microbiota composition or altered barrier function can lead to the activation of Toll-like and Nod-like receptors in the innate immune system by gut microbial products. TLR/NLR activation can drive proinflammatory gene expression, thereby promoting liver disease. Changes in people’s dietary habits include increased intestinal permeability, increased serum endotoxin levels, and moderate increases in the levels of proinflammatory cytokines associated with various aspects of metabolic syndrome (including NAFLD) (Pendyala et al., 2012). The alteration of the intestinal microbiota and permeability due to alcohol can result in heightened activation of the liver TLR/NLR, thus leading to the emergence of liver disease (Lu et al., 2011). Additionally, lipopolysaccharide, which is a toxic substance originating from gram-negative bacteria found in the intestines, contributes to the progression of liver damage by stimulating liver cells to generate TNF. TNF then travels through the bloodstream and enhances the permeability of the blood-brain barrier, ultimately causing hepatic encephalopathy (Ma et al., 2004).
Many studies have shown that gut microbes participate in the progression of HBV through their metabolites and influence autoimmunity and can also be used as markers of the prognosis of patients with HBV (Xu et al., 2012; Yang et al., 2018; Sun et al., 2021; Wang et al., 2021). People also use the interaction between intestinal microbes and the liver to intervene in and treat liver diseases. For example, Guo et al. (2022) others have used traditional Chinese medicine to act on the intestinal liver axis to intervene in the treatment of nonalcoholic fatty disease (NAFLD).
In addition, Shahbazi et al. (2023) reported that advanced liver disease and cirrhosis alter the composition of the gut microbiota and that altering the microbiota produces different metabolites, damages the gut barrier, leads to bacterial translocation, and alters bacterial metabolites and products (i.e., DNA, LPS, etc.). By triggering the innate immune system, which initiates the production of proinflammatory cytokines, systemic inflammation activates sinusoidal blight cells, leading to hepatocellular damage, hepatocellular damage with gut-derived products and metabolites compromising the integrity of the blood–brain barrier (BBB). Restoration of the gut flora improves cognitive dysfunction in hepatic encephalopathy (Zhu J. et al., 2023). All of the above studies reflect the interaction between the gut microbiota and liver disease and the progress of research on the gut-liver axis.
5 The GM and IDD
Researchers have never stopped studying the effect of microorganisms on disk degeneration, the most representative being the effect of Propionibacterium acnes on disk degeneration (Table 2). Chen et al. (2016) observed changes in MRI and histology by injecting Propionibacterium acnes, Staphylococcus aureus (S. aureus) and rabbits. The control showed that the disk caused changes and intervertebral discitis caused by S. aureus, and the pathological changes caused by Propionibacterium acnes (P. acnes)were considered to be Modic-I changes and disk degeneration; however, Ahmed-Yahia et al. (2019) However, whether acnes cause Modic-I changes has not been determined through clinical experiments. Yuan et al. (2017) reported that histological evidence also supported a link between P. acnes and disk degeneration. Clinical trials such as those by Magno da Rocha et al. (2023) are also exploring the link between the two. Research has revealed that the influence of P. acnes on disk degeneration causes pyroptosis of the nucleus pulposus via ROS-NLRP3 and exacerbates disk deterioration (Tang et al., 2021). In addition, P. acnes promotes cell apoptosis in the nucleus pulposus through the TLR 2/JNK/mitochondria-mediated pathway and induces intervertebral disk degeneration (Lin et al., 2018). In addition, Lan et al. (2022) found that different systemic types of acne caused different patterns of disk degeneration. With the continuous exploration of the influence of microorganisms on disk degeneration, whether the intestinal microbiota is involved in disk degeneration has become a hot topic in related research.
Table 2. Recent correlative studies on the effects of P. acnes on IDD.
Dysbiosis of the gut microbiota results in the abnormal production of several metabolites, signaling molecules, and immune cells that may affect the musculoskeletal system (Ratna et al., 2023). Li et al. (2022) described three potential mechanisms by which the GM induces IVD and leads to LBP (Figure 3 and Table 3). In the first pathway, bacteria cross the intestinal epithelial barrier and enter the IVD. In a low-acid hypoxic environment, microbes can colonize and multiply (McDonnell et al., 2023). When the intestinal microbial system is disturbed or intestinal inflammation occurs, the intestinal epithelial barrier is destroyed, the permeability of the intestine increases, and more intestinal bacteria pass through the intestinal epithelial barrier (Thevaranjan et al., 2018). Although most bacteria are eliminated by the immune system, a few escape the immune system, reaching bacteria near the IVD or entering the IVD by releasing proinflammatory factors (such as IL-6 and TNF-α) to recruit more inflammatory cells (such as T cells, B cells, dendritic cells and macrophages) (Schirmer et al., 2016) while stimulating IVD cells to secrete inflammatory cytokines, such as IL-1α/β, IL-17, TNF-α, and IL-6 (Risbud and Shapiro, 2014). Moreover, these cytokines destroy the IVD extracellular matrix (ECM) by promoting the degradation of aggrecan and collagen. A series of chain reactions initiated by these cytokines leads to the production of chemokines that further impair the ECM (Hampton and Chtanova, 2019). Furthermore, the release of inflammatory molecules secreted by the damaged IVD and the activation of macrophages, T and B cells, mast cells, and neutrophils further amplify the inflammatory cascade, which leads to IDD. Bacterial translocation into the IVD can also lead to the activation of these immune cells through the release of lipopolysaccharide (LPS) and cause persistent pain.
Figure 3. Dysregulation of intestinal homeostasis, intestinal bacteria and the production of metabolic wastes, various nutrients and immune cells, etc., enter the blood circulation and pass through (A) Bacteria Infiltration, (B) Injury-Induced Inflammation, (C) Metabolites and cytokines. Three pathways are involved in the process of disk degeneration. The intervertebral disk constitutes the intestinal disk axis. SCFAs, short-chain fatty acids; LPS, lipopolysaccharide.
Table 3. Three potential pathways by which gut microbes may influence IDD.
The second pathway involves systemic and mucosal immunomodulation. Excessive contact between intestinal bacteria and the intestinal mucosa leads to the activation of the immune system and increases the number of immune cells that release competent proinflammatory factors such as IL-6 and TNF-α into the blood to regulate bone metabolism. These inflammatory cytokines and activated immune cells can migrate near the IVD. The infiltration of these products can cause long-range inflammation that causes IVD, and products such as SCFAS can affect the development of bone (Mortensen and Clausen, 1996; Zaiss et al., 2019).
The third path involves balancing nutrient absorption and the formation of intestinal epithelial metabolites and their diffusion into the IVD. In cirrhosis, diabetes, obesity, neurological diseases, and intestinal flora disorders, under the influence of these factors of intestinal toxins, inflammatory cytokines, microorganisms and microbial metabolites interfere with the production of mucin by cup cells and intestinal barrier damage, causing intestinal bacterial translocation and the transfer of toxic metabolites such as endotoxin/LPS, SCFAs/D-lactic acid and inflammatory factors (Sun et al., 2021; Li et al., 2022; Anachad et al., 2023). These inflammatory factors and metabolites can cause remote inflammation of the IVD, and SCFAs can promote the differentiation of primary CD4++ cells to Tregs. Tregs preferentially stay on the endosteal surface, promote osteoblast differentiation, and inhibit the formation of osteoclasts; at the same time, they are necessary for parathyroid hormone stimulation (parathyroid hormone, pth stimulation) and bone formation (Fujisaki et al., 2011; Qiu et al., 2015; Yu et al., 2018). In addition, SCFAs are removed by the activation of G protein-coupled receptors (GPCRs), or the inhibition of HDACs has a direct effect on bone resorption or osteoclast formation. Calcium deposition in the disk and the expression of extracellular calcium-sensitive receptors (extracellular calcium-sensing receptors, CaSR) are closely associated with GPCRs in degenerative disks, suggesting that the diffusion of intestinal-derived SCFAs to the IVD can lead to calcification and IDD (Kotterman et al., 2015; Li et al., 2022). Under the combined action of the above factors, the hypooxygen environment of infiltrating IVDs with inflammation is disrupted, and the ECM is destroyed by the degradation of cytokines, leading to IDD-related damage to the IVD (Risbud and Shapiro, 2014; Hampton and Chtanova, 2019).
As we all know, vitamin D plays an important role in human bone health (Bouillon et al., 2019). All cells that make up the bones (chondrocytes, osteoblasts and osteoclasts) contain vitamin D receptors and the enzyme CYP27B1, which are required for the production of the active metabolite of vitamin D, 1,25-dihydroxyvitamin D (Bikle, 2012). Intestinal microorganisms can affect the metabolism of vitamin D (such as Carnosaurus maltiferus), which in turn affects the health of bones (including intervertebral disks) (Li et al., 2023). In addition, it has been suggested that environmental factors such as pollution, diet, and lifestyle may play a crucial role in autoimmune diseases in conjunction with genetic traits (Murdaca et al., 2021). In particular, vitamin D has been negatively associated with the development of several autoimmune diseases. Murdaca and Gangemi (2022) found that vitamin D plays an important role in calcium homeostasis and bone metabolism, possesses anti-inflammatory and antioxidant properties, and acts on both innate and adaptive immunity. In the human body, gut microbes and vitamin D interact in many different ways to profoundly affect the immune system. Vitamin D is a key mediator in the interconnection between gut microbes and the immune system. It follows that gut microbes can influence their immune system by interfering with the metabolism of microbial vitamin D and thereby (Murdaca et al., 2021). This leads to a series of responses such as oxidative stress and inflammation, which further induce or accelerate IDD.
6 Current research status of GM and IDD
To verify the relationship between intestinal microorganisms and intervertebral disk degeneration. Whether it is expected to become a new target for intervention in IDD. The researchers conducted a series of studies (Table 4).
Table 4. Research progress on gut microorganisms and IDD.
Mendelian randomization (MR) is a statistical method used to estimate the causal effect of exposure factors (e.g., lifestyle or biomarkers) on outcome variables (e.g., disease or health outcomes) and is often used to verify the causal effect of both factors. Geng et al. (2023) used the inverse variance weighting (IVW) method as the main MR (two-way two-sample Mendelian randomization study) analysis method. The weighted median, MR-Egger regression, weighted mode and simple mode were used as supplements. Level pleiotropy (MR-outliers PRESSO) and MR-Egger regression. Cochran’s Q test was used to assess heterogeneity, and reverse MR analysis was used to assess potential reverse causality. Two-way two-sample Mendelian randomization analysis of 211 gut microbial taxa and IDD revealed eight nominal causalities and strong correlations, which further supported the concept of the disk axis. Fang et al. also used Mendelian randomization studies to verify the causal relationship between gut microbiota and IDD (Fang et al., 2024).
In one study, 6 disks (3 controls and 3 cases) were selected for mass spectrometry identification. After excluding metabolites related to humans, drugs, and food, 39 bacterial-specific metabolites were isolated. Nine metabolites were found to have significant fold changes > 1.0, including (S)-14-methylhexadecanoic acid related to P. acnes, 9-OxoODE and 13-OxoODE related to intestinal flora, Vibrio (siderophores), tuberculin and isotuberculol, virulence factors of Mycobacterium tuberculosis. This also provides evidence for the involvement of intestinal microorganisms in IDD (Rajasekaran et al., 2023).
Using 2-month-old male Sprague–Dawley rats, Yao et al. (2023) established an experimental model of IDD. FMT (fecal microbiota transplantation) was performed by gastric gavage of IDD rats with fecal bacterial solution. After surgery, rat serum, feces and disk tissue were collected for 2 months. TNF-α, IL-1β, IL-6, matrix metalloproteinase (MMP)-3, MMP-13, and collagen II. The levels of aggrecan were assessed using enzyme-linked immunosorbent assay, immunohistochemistry, real-time polymerase chain reaction, or protein blotting. The pathology of the disk tissue was also examined using hematoxylin and eosin (HE) and red O-fast green staining. The intestinal microbiota in rat feces was also examined using 16S rRNA gene sequencing. In the IDD group, the rats in the IDD group had severely impaired disk tissue, disordered cell arrangement, uneven pupanin coloring, and increased expression of TNF-α, IL-1β, IL-6, MMP-3, MMP-13, NLRP3 and Caspase-1, while collagen II and aggrecan levels were decreased. FMT reversed the effects of IDD on these factors and alleviated damage to cartilage tissue. FMT increased the gut microbiota diversity and microbial abundance in IDD-treated rats. This finding also provides further evidence for the effect of the gut microbiota on IDD. Cheng et al. also used 16S rRNA gene sequencing to verify the impact of intestinal microorganisms on IDD and the relationship between the two in an IDD model established in rabbits (Cheng et al., 2024).
In the latest study, Wang et al. established a rat IDD puncture model and treated it with Sanbi decoction (SBD) tube feeding at different concentrations. After 4 weeks, clean feces, serum, liver, kidney and intervertebral disk (IVD) were collected and tested using the same method as Yao et al. The results show that SBD can extensively regulate intestinal flora and serum metabolic homeostasis, reduce inflammatory responses, inhibit ECM degradation, restore IVD height and water content, and has a significant therapeutic effect on IDD. This provides a basis for intestinal microorganisms to become a new target for the treatment of IDD, and further proves the connection between intestinal microorganisms and IDD (Wang et al., 2024).
7 GM regulation therapy for IDD
Traditional treatments such as medication and surgery are commonly used for IDD, and the global prevalence of this condition highlights the critical necessity for impactful therapeutic solutions that can help ease symptoms and delay the progression of IDD. In recent years, with continuous research and exploration, many promising influences as well as therapeutic approaches to improve and treat IDD have been identified (Samanta et al., 2023). Gut microbes are promising targets for therapeutic strategies because they can be modified by lifestyle changes, such as dietary interventions, sleep and exercise, fecal transplantation, and future microbiome-targeted therapy (Konturek et al., 2015; Morimoto et al., 2023).
7.1 Lifestyle changes
A healthy lifestyle can improve gut microbial abundance and species (increasing “good” bacteria) and may improve gut flora disorders (Li et al., 2016). Improving intestinal dysbiosis can reduce immune and inflammatory responses, improve the environment of the IVD, delay the process of IDD, and improve bone quality by relieving pain through short-chain fatty acids or neurotransmitters (Hampton and Chtanova, 2019; Zaiss et al., 2019). A high-fat diet can cause unhealthy obesity and increase cholesterol in the body. Morimoto et al. (2023) reported that cholesterol can induce cell pyroptosis and matrix degradation through mSREBP1-driven intervertebral disk degeneration. Prebiotics, such as fiber and oligosaccharides, are indigestible substances found in food. They promote the growth and function of helpful bacteria in the gut, leading to positive effects on health by assisting in the production of SCFAs, influencing cell development, hormone release, and inflammation control, and providing advantages to the host. It also plays an important role in maintaining healthy gut microbial homeostasis by promoting epithelial barrier function and reducing dysbiosis, stimulating the production of antimicrobial substances and immunoglobulin, and inhibiting the production of bacterial toxins, thus promoting the host immune response and anti-inflammatory pathways (Li et al., 2016; Zhang et al., 2023). In conclusion, maintaining a healthy lifestyle can maintain or improve intestinal homeostasis, and the maintenance of gut microbes reduces the range of its effects on disk degeneration.
7.2 FMT
FMT refers to the transplantation of processed healthy populations of fecal flora to patients. FMT can rebuild the intestinal flora, regulate intestinal flora imbalance, and rebuild the normal function of the intestinal ecosystem, with curative effects, fewer side effects, a short course, and a low recurrence rate. FMT has been used to treat gastrointestinal diseases, including constipation, inflammatory bowel disease, Parkinson’s disease, and multiple sclerosis (Wang et al., 2022; Zhang et al., 2022). Yao et al. (2023) in other experiments, FMT was used to verify the relationship between the gut microbiota and IDD, and FMT improved the effect of intestinal dysbiosis on IDD through FMT. FMT, or fecal microbiota transplantation, refers to the transplantation of treated fecal flora from healthy people into patients to rebuild the intestinal flora, regulate the imbalance of intestinal flora, and reestablish the normal function of intestinal ecosystems. Fecal microbiota transplants, which have the advantages of good efficacy, few side effects, a short course of treatment, and a low recurrence rate, have been used to treat gastrointestinal disorders, including constipation, inflammatory bowel disease (IBD), parkinsonism, and multiple sclerosis (Zhu H. et al., 2022; Zhu J. et al., 2023). Zhan et al. (2021) constructed an IDD model using rats, verified the relationship between the gut microbiota and IDD using FMT, and demonstrated that FMT ameliorated the effects of gut flora dysbiosis on IDD. Cheng et al. constructed an IDD model using rabbits, and the results showed that IDD altered the intestinal microbiota and fecal metabolites in the rabbit model and that multiple metabolites were elevated in the IDD model in association with a variety of gut bacteria. These results provide a direction and theoretical basis for the clinical application of FMT to modulate the gut flora in the treatment of IDD-induced low back pain (Cheng et al., 2024). FMT may be a promising target for improving IDD and palliative care and may become a promising target for improving IDD and palliative treatment.
When gut microorganisms are disrupted in the intestinal environment due to diseases of other organs or systems and the intestinal flora is dysregulated, all of these conditions can induce the development of IDD or accelerate the process of IDD. Conversely, the gut flora can be restored by therapeutic interventions in the gut-disk axis to prevent the onset and progression of IDD (Yao et al., 2023; Wang et al., 2024).
8 Conclusion and perspective
Ever since Rajasekaran discovered that intervertebral disks and gut microbes share bacterial genera, scientists have been exploring the relationship between the two. In animal models, it has been confirmed that intestinal microorganisms and their metabolites are involved in the formation and progression of IDD. However, the research on the involvement of intestinal microorganisms and their metabolites in IDD is still in the preliminary exploration stage. Intestinal microorganisms, as well as calcium, phosphorus, short-chain fatty acids SCFA, immune factors, etc. The imbalance of these intestinal flora and substances produced by metabolism may lead to changes in the body’s immunity and inflammation, and further cascade reactions may occur, affecting the normal function of IVD. Structure and function. Therefore, an in-depth understanding of the potential mechanisms by which intestinal microbes participate in IDD, as well as exploring strategies to intervene in the impact of intestinal microorganisms on IDD, will be beneficial to the subsequent treatment of IDD.
Gut microbial therapies targeting IDD have been partially investigated in preclinical studies with success. But there are also shortcomings. Although most preclinical studies are able to reflect the relationship between the two, as well as the changes in IDD and its mechanisms when changing the intestinal microbiota, heterogeneity exists between organisms. IDD is a gradual development process. Only changes in the intestinal flora of experimental animals with severe IDD and normal controls were observed. The sample size is small and the results are not generalizable. In future studies, researchers need to increase the sample size, dynamically observe the changes in intestinal flora from mild to severe IDD, and conduct clinical studies in a timely manner to explore whether the two have the same relationship in the human body. To gain a deeper understanding of the mechanism by which intestinal microorganisms participate in IDD, as well as the changes in intestinal microorganisms during the process of IDD. It will provide innovative ideas and strategies for the treatment of IDD and lay the foundation for intestinal microorganisms to become a new target for delaying or treating IDD.
Author contributions
KW: Writing – original draft. XL: Conceptualization, Writing – review and editing. HH: Writing – review and editing. MS: Writing – review and editing. JW: Writing – review and editing. XL: Writing – review and editing. JZ: Data curation, Resources, Writing – review and editing. XC: Writing – review and editing. ZL: Funding acquisition, Writing – review and editing.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Science and Technology Innovation Foundation of Dalian (2022JJ12SN045), the Dalian Medical Science Research Program (2023DF009), the Natural Science Foundation of Liaoning Province (2022-MS-322) and the Medical-Industrial Joint Innovation Funding Project of First Hospital of Dalian Medical University and Dalian Institute of Chemical Physics (DMU-1&DICP UN202311). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Afzaal, M., Saeed, F., Shah, Y. A., Hussain, M., Rabail, R., Socol, C. T., et al. (2022). Human gut microbiota in health and disease: Unveiling the relationship. Front. Microbiol. 13:999001. doi: 10.3389/fmicb.2022.999001
Ahmed-Yahia, S., Decousser, J. W., Flouzat-Lachaniette, C. H., Dervin, G., Roubineau, F., Audureau, E., et al. (2019). Is the discopathy associated with Modic changes an infectious process? Results from a prospective monocenter study. PLoS One 14:e0221030. doi: 10.1371/journal.pone.0221030
Anachad, O., Taouil, A., Taha, W., Bennis, F., and Chegdani, F. (2023). the implication of short-chain fatty acids in obesity and diabetes. Microbiol. Insights 16:11786361231162720.
Behera, J., Ison, J., Tyagi, S. C., and Tyagi, N. (2020). The role of gut microbiota in bone homeostasis. Bone 135:115317.
Bora, S. A., Kennett, M. J., Smith, P. B., Patterson, A. D., and Cantorna, M. T. (2018). The gut microbiota regulates endocrine vitamin D metabolism through fibroblast growth factor 23. Front. Immunol. 9:408. doi: 10.3389/fimmu.2018.00408
Bouillon, R., Marcocci, C., Carmeliet, G., Bikle, D., White, J. H., Dawson-Hughes, B., et al. (2019). Skeletal and extraskeletal actions of vitamin D: Current evidence and outstanding questions. Endocr. Rev. 40, 1109–1151. doi: 10.1210/er.2018-00126
Boxberger, J. I., Orlansky, A. S., Sen, S., and Elliott, D. M. (2009). Reduced nucleus pulposus glycosaminoglycan content alters intervertebral disc dynamic viscoelastic mechanics. J. Biomech. 42, 1941–1946. doi: 10.1016/j.jbiomech.2009.05.008
Browning, K. N. (2015). Role of central vagal 5-HT3 receptors in gastrointestinal physiology and pathophysiology. Front. Neurosci. 9:413. doi: 10.3389/fnins.2015.00413
Buchbinder, R., van Tulder, M., Öberg, B., Costa, L. M., Woolf, A., Schoene, M., et al. (2018). Low back pain: A call for action. Lancet 391, 2384–2388.
Chassaing, B., Etienne-Mesmin, L., and Gewirtz, A. T. (2014). Microbiota-liver axis in hepatic disease. Hepatology 59, 328–339.
Chen, Y., Wang, X., Zhang, C., Liu, Z., Li, C., and Ren, Z. (2022). Gut microbiota and bone diseases: A growing partnership. Front. Microbiol. 13:877776. doi: 10.3389/fmicb.2022.877776
Chen, Z., Zheng, Y., Yuan, Y., Jiao, Y., Xiao, J., Zhou, Z., et al. (2016). Modic changes and disc degeneration caused by inoculation of propionibacterium acnes inside intervertebral discs of rabbits: A pilot study. Biomed. Res. Int. 2016:9612437. doi: 10.1155/2016/9612437
Cheng, S., Yu, J., Cui, M., Su, H., and Cao, Y. (2024). Changes in the composition of the fecal metabolome and gut microbiota contribute to intervertebral disk degeneration in a rabbit model. J. Orthop. Surg. Res. 19:6. doi: 10.1186/s13018-023-04486-x
Colombini, A., Lombardi, G., Corsi, M. M., and Banfi, G. (2008). Pathophysiology of the human intervertebral disc. Int. J. Biochem. Cell Biol. 40, 837–842.
Cork, S. C. (2018). The role of the vagus nerve in appetite control: Implications for the pathogenesis of obesity. J. Neuroendocrinol. 30:e12643. doi: 10.1111/jne.12643
Dickinson, P. J., and Bannasch, D. L. (2020). Current understanding of the genetics of intervertebral disc degeneration. Front. Vet. Sci. 7:431. doi: 10.3389/fvets.2020.00431
Dowdell, J., Erwin, M., Choma, T., Vaccaro, A., Iatridis, J., and Cho, S. K. (2017). Intervertebral disk degeneration and repair. Neurosurgery 80, S46–S54.
Fan, C., Chu, G., Yu, Z., Ji, Z., Kong, F., Yao, L., et al. (2023). The role of ferroptosis in intervertebral disc degeneration. Front. Cell. Dev. Biol. 11:1219840. doi: 10.3389/fcell.2023.1219840
Fang, M., Liu, W., Wang, Z., Li, J., Hu, S., Li, Z., et al. (2024). Causal associations between gut microbiota with intervertebral disk degeneration, low back pain, and sciatica: A Mendelian randomization study. Eur. Spine J. 33, 1424–1439.
Fujisaki, J., Wu, J., Carlson, A. L., Silberstein, L., Putheti, P., Larocca, R., et al. (2011). In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 474, 216–219. doi: 10.1038/nature10160
Geng, Z., Wang, J., Chen, G., Liu, J., Lan, J., Zhang, Z., et al. (2023). Gut microbiota and intervertebral disc degeneration: A bidirectional two-sample Mendelian randomization study. J. Orthop. Surg. Res. 18:601. doi: 10.1186/s13018-023-04081-0
Gomes, A. C., Hoffmann, C., and Mota, J. F. (2018). The human gut microbiota: Metabolism and perspective in obesity. Gut Microbes 9, 308–325.
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., et al. (2019). Cellular senescence: Defining a path forward. Cell 179, 813–827. doi: 10.1016/j.cell.2019.10.005
Guo, K., Xu, S., and Zeng, Z. (2022). “Liver-gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease. Front. Endocrinol. 13:1050709. doi: 10.3389/fendo.2022.1050709
Hampton, H. R., and Chtanova, T. (2019). Lymphatic migration of immune cells. Front. Immunol. 10:1168. doi: 10.3389/fimmu.2019.01168
Hartvigsen, J., Hancock, M. J., Kongsted, A., Louw, Q., Ferreira, M. L., Genevay, S., et al. (2018). What low back pain is and why we need to pay attention. Lancet 391, 2356–2367. doi: 10.1016/S0140-6736(18)30480-X
Hrncir, T., Hrncirova, L., Kverka, M., and Tlaskalova-Hogenova, H. (2019). The role of gut microbiota in intestinal and liver diseases. Lab. Anim. 53, 271–280.
Kohgo, Y. (2001). [Disorders of iron metabolism involving erythropoiesis: Molecular mechanism of gut-liver-bone marrow axis]. Rinsho Ketsueki 42, 397–402.
Konturek, P. C., Haziri, D., Brzozowski, T., Hess, T., Heyman, S., Kwiecien, S., et al. (2015). Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases. J. Physiol. Pharmacol. 66, 483–491.
Kotterman, M. A., Chalberg, T. W., and Schaffer, D. V. (2015). Viral vectors for gene therapy: Translational and clinical outlook. Annu. Rev. Biomed. Eng. 17, 63–89.
Kritschil, R., Scott, M., Sowa, G., and Vo, N. (2022). Role of autophagy in intervertebral disc degeneration. J. Cell Physiol. 237, 1266–1284.
Lagier, J. C., Khelaifia, S., Alou, M. T., Ndongo, S., Dione, N., Hugon, P., et al. (2016). Culture of previously uncultured members of the human gut microbiota by culturomics. Nat. Microbiol. 1:16203. doi: 10.1038/nmicrobiol.2016.203
Lakstins, K., Arnold, L., Gunsch, G., Flanigan, D., Khan, S., Gadde, N., et al. (2021). Characterization of the human intervertebral disc cartilage endplate at the molecular, cell, and tissue levels. J. Orthop. Res. 39, 1898–1907. doi: 10.1002/jor.24854
Lan, W., Wang, X., Tu, X., Hu, X., and Lu, H. (2022). Different phylotypes of Cutibacterium acnes cause different modic changes in intervertebral disc degeneration. PLoS One 17:e0270982. doi: 10.1371/journal.pone.0270982
Li, Q., Chan, H., Liu, W. X., Liu, C. A., Zhou, Y., Huang, D., et al. (2023). Carnobacterium maltaromaticum boosts intestinal vitamin D production to suppress colorectal cancer in female mice. Cancer Cell 41:1450–1465.e1458. doi: 10.1016/j.ccell.2023.06.011
Li, W., Lai, K., Chopra, N., Zheng, Z., Das, A., and Diwan, A. D. (2022). Gut-disc axis: A cause of intervertebral disc degeneration and low back pain? Eur. Spine J. 31, 917–925. doi: 10.1007/s00586-022-07152-8
Li, Y., Luo, W., Deng, Z., and Lei, G. (2016). Diet-intestinal microbiota axis in osteoarthritis: A possible role. Mediat. Inflamm. 2016:3495173. doi: 10.1155/2016/3495173
Lin, X., Xiao, H. M., Liu, H. M., Lv, W. Q., Greenbaum, J., Gong, R., et al. (2023). Gut microbiota impacts bone via Bacteroides vulgatus-valeric acid-related pathways. Nat. Commun. 14:6853. doi: 10.1038/s41467-023-42005-y
Lin, Y., Jiao, Y., Yuan, Y., Zhou, Z., Zheng, Y., Xiao, J., et al. (2018). Propionibacterium acnes induces intervertebral disc degeneration by promoting nucleus pulposus cell apoptosis via the TLR2/JNK/mitochondrial-mediated pathway. Emerg. Microbes Infect. 7:1. doi: 10.1038/s41426-017-0002-0
Lu, H., Wu, Z., Xu, W., Yang, J., Chen, Y., and Li, L. (2011). Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients. Microb. Ecol. 61, 693–703. doi: 10.1007/s00248-010-9801-8
Lv, F., Leung, V. Y., Huang, S., Huang, Y., Sun, Y., and Cheung, K. M. (2014). In search of nucleus pulposus-specific molecular markers. Rheumatology 53, 600–610. doi: 10.1093/rheumatology/ket303
Ma, T. Y., Iwamoto, G. K., Hoa, N. T., Akotia, V., Pedram, A., Boivin, M. A., et al. (2004). TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G367–G376.
Magno da Rocha, V., Lima, C., Ferreira, E. O., de Farias, G. C., Nogueira, F. C. S., Martha Antunes, L. C., et al. (2023). Colonization of intervertebral discs by Cutibacterium acnes in patients with low back pain: Protocol for an analytical study with microbiological, phenotypic, genotypic, and multiomic techniques. PLoS One 18:e0271773. doi: 10.1371/journal.pone.0271773
Martirosyan, N. L., Patel, A. A., Carotenuto, A., Kalani, M. Y., Belykh, E., Walker, C. T., et al. (2016). Genetic alterations in intervertebral disc disease. Front. Surg. 3:59. doi: 10.3389/fsurg.2016.00059
McDonnell, E. E., Wilson, N., Barcellona, M. N., Bagnall, J., Brama, P. A. J., Cunniffe, G. M., et al. (2023). Preclinical to clinical translation for intervertebral disc repair: Effects of species-specific scale, metabolism, and matrix synthesis rates on cell-based regeneration. JOR Spine 6:e1279. doi: 10.1002/jsp2.1279
Minemura, M., and Shimizu, Y. (2015). Gut microbiota and liver diseases. World J. Gastroenterol. 21, 1691–1702.
Mohd Isa, I. L., Teoh, S. L., Mohd Nor, N. H., and Mokhtar, S. A. (2022). Discogenic low back pain: Anatomy, pathophysiology and treatments of intervertebral disc degeneration. Int. J. Mol. Sci. 24:208.
Molladavoodi, S., McMorran, J., and Gregory, D. (2020). Mechanobiology of annulus fibrosus and nucleus pulposus cells in intervertebral discs. Cell Tissue Res. 379, 429–444.
Moon, S. M., Yoder, J. H., Wright, A. C., Smith, L. J., Vresilovic, E. J., and Elliott, D. M. (2013). Evaluation of intervertebral disc cartilaginous endplate structure using magnetic resonance imaging. Eur. Spine J. 22, 1820–1828.
Morimoto, T., Kobayashi, T., Kakiuchi, T., Esaki, M., Tsukamoto, M., Yoshihara, T., et al. (2023). Gut-spine axis: A possible correlation between gut microbiota and spinal degenerative diseases. Front. Microbiol. 14:1290858. doi: 10.3389/fmicb.2023.1290858
Mortensen, P. B., and Clausen, M. R. (1996). Short-chain fatty acids in the human colon: Relation to gastrointestinal health and disease. Scand. J. Gastroenterol. Suppl. 216, 132–148.
Murdaca, G., Gerosa, A., Paladin, F., Petrocchi, L., Banchero, S., and Gangemi, S. (2021). Vitamin D and microbiota: Is there a link with allergies? Int. J. Mol. Sci. 22:4288.
Murdaca, G., Greco, M., Borro, M., and Gangemi, S. (2021). Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms. Autoimmun. Rev. 20:102845.
Newell, N., Little, J. P., Christou, A., Adams, M. A., Adam, C. J., and Masouros, S. D. (2017). Biomechanics of the human intervertebral disc: A review of testing techniques and results. J. Mech. Behav. Biomed. Mater. 69, 420–434.
Ohnishi, T., Iwasaki, N., and Sudo, H. (2022). Causes of and molecular targets for the treatment of intervertebral disc degeneration: A review. Cells 11:394.
Patil, P., Falabella, M., Saeed, A., Lee, D., Kaufman, B., Shiva, S., et al. (2019). Oxidative stress-induced senescence markedly increases disc cell bioenergetics. Mech. Ageing Dev. 180, 97–106. doi: 10.1016/j.mad.2019.04.006
Pendyala, S., Walker, J. M., and Holt, P. R. (2012). A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 142:1100–1101.e1102.
Qiu, X., Gui, Y., Xu, Y., Li, D., and Wang, L. (2015). DHEA promotes osteoblast differentiation by regulating the expression of osteoblast-related genes and Foxp3(+) regulatory T cells. Biosci. Trends 9, 307–314. doi: 10.5582/bst.2015.01073
Rajasekaran, S., Soundararajan, D. C. R., Tangavel, C., Muthurajan, R., Sri Vijay Anand, K. S., Matchado, M. S., et al. (2020). Human intervertebral discs harbour a unique microbiome and dysbiosis determines health and disease. Eur. Spine J. 29, 1621–1640. doi: 10.1007/s00586-020-06446-z
Rajasekaran, S., Tangavel, C., Vasudevan, G., Easwaran, M., Muthurajan, R., Murugan, C., et al. (2023). Bacteria in human lumbar discs - subclinical infection or contamination? Metabolomic evidence for colonization, multiplication, and cell-cell cross-talk of bacteria. Spine J. 23, 163–177.
Ratna, H. V. K., Jeyaraman, M., Yadav, S., Jeyaraman, N., and Nallakumarasamy, A. (2023). Is dysbiotic gut the cause of low back pain? Cureus 15:e42496. doi: 10.7759/cureus.42496
Risbud, M. V., and Shapiro, I. M. (2014). Role of cytokines in intervertebral disc degeneration: Pain and disc content. Nat. Rev. Rheumatol. 10, 44–56.
Samanta, A., Lufkin, T., and Kraus, P. (2023). Intervertebral disc degeneration-Current therapeutic options and challenges. Front. Public Health 11:1156749. doi: 10.3389/fpubh.2023.1156749
Savontaus, E. I, Conwell, M., and Wardlaw, S. L. (2002). Effects of adrenalectomy on AGRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats. Brain Res. 958, 130–138. doi: 10.1016/s0006-8993(02)03674-0
Schirmer, M., Smeekens, S. P., Vlamakis, H., Jaeger, M., Oosting, M., Franzosa, E. A., et al. (2016). Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 167:1897.
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., and Baskin, D. G. (2000). Central nervous system control of food intake. Nature 404, 661–671.
Seely, K. D., Kotelko, C. A., Douglas, H., Bealer, B., and Brooks, A. E. (2021). The human gut microbiota: A key mediator of osteoporosis and osteogenesis. Int. J. Mol. Sci. 22:9452.
Shahbazi, A., Sepehrinezhad, A., Vahdani, E., Jamali, R., Ghasempour, M., Massoudian, S., et al. (2023). Gut dysbiosis and blood-brain barrier alteration in hepatic encephalopathy: From gut to brain. Biomedicines 11:1272. doi: 10.3390/biomedicines11051272
Sun, X., Pan, C. Q., and Xing, H. (2021). Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection. Hepatol. Int. 15, 1053–1067.
Tang, G., Han, X., Lin, Z., Qian, H., Chen, B., Zhou, C., et al. (2021). Propionibacterium acnes accelerates intervertebral disc degeneration by inducing pyroptosis of nucleus pulposus cells via the ROS-NLRP3 pathway. Oxid. Med. Cell Longev. 2021:4657014. doi: 10.1155/2021/4657014
Thevaranjan, N., Puchta, A., Schulz, C., Naidoo, A., Szamosi, J. C., Verschoor, C. P., et al. (2018). Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction. Cell Host Microbe 23:570.
Travagli, R. A., and Rogers, R. C. (2001). Receptors and transmission in the brain-gut axis: Potential for novel therapies. V. Fast and slow extrinsic modulation of dorsal vagal complex circuits. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G595–G601. doi: 10.1152/ajpgi.2001.281.3.G595
Vergroesen, P. P., Kingma, I., Emanuel, K. S., Hoogendoorn, R. J., Welting, T. J., van Royen, B. J., et al. (2015). Mechanics and biology in intervertebral disc degeneration: A vicious circle. Osteoarthritis Cartil. 23, 1057–1070.
Visconti, A., Le Roy, C. I., Rosa, F., Rossi, N., Martin, T. C., Mohney, R. P., et al. (2019). Interplay between the human gut microbiome and host metabolism. Nat. Commun. 10:4505.
Vo, N. V., Hartman, R. A., Patil, P. R., Risbud, M. V., Kletsas, D., Iatridis, J. C., et al. (2016). Molecular mechanisms of biological aging in intervertebral discs. J. Orthop. Res. 34, 1289–1306.
Wang, K., Zhang, Z., Mo, Z. S., Yang, X. H., Lin, B. L., Peng, L., et al. (2021). Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure. Gut Microbes 13, 1–15. doi: 10.1080/19490976.2021.1921925
Wang, N., Chen, S., Xie, Y., Liu, X., Xi, Z., Li, J., et al. (2024). The Sanbi decoction alleviates intervertebral disc degeneration in rats through intestinal flora and serum metabolic homeostasis modulation. Phytomedicine 127:155480. doi: 10.1016/j.phymed.2024.155480
Wang, Y., Zhang, S., Borody, T. J., and Zhang, F. (2022). Encyclopedia of fecal microbiota transplantation: A review of effectiveness in the treatment of 85 diseases. Chin. Med. J. 135, 1927–1939. doi: 10.1097/CM9.0000000000002339
Wu, A., March, L., Zheng, X., Huang, J., Wang, X., Zhao, J., et al. (2020). Global low back pain prevalence and years lived with disability from 1990 to 2017: Estimates from the global burden of disease study 2017. Ann. Transl. Med. 8:299.
Wu, Y., Shen, S., Shi, Y., Tian, N., Zhou, Y., and Zhang, X. (2022). Senolytics: Eliminating senescent cells and alleviating intervertebral disc degeneration. Front. Bioeng. Biotechnol. 10:823945. doi: 10.3389/fbioe.2022.823945
Xu, J., Shao, T., Lou, J., Zhang, J., and Xia, C. (2023). Aging, cell senescence, the pathogenesis and targeted therapies of intervertebral disc degeneration. Front. Pharmacol. 14:1172920. doi: 10.3389/fphar.2023.1172920
Xu, M., Wang, B., Fu, Y., Chen, Y., Yang, F., Lu, H., et al. (2012). Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease. Microb. Ecol. 63, 304–313. doi: 10.1007/s00248-011-9925-5
Xu, W. N., Zheng, H. L., Yang, R. Z., Liu, T., Yu, W., Zheng, X. F., et al. (2019). Mitochondrial NDUFA4L2 attenuates the apoptosis of nucleus pulposus cells induced by oxidative stress via the inhibition of mitophagy. Exp. Mol. Med. 51, 1–16. doi: 10.1038/s12276-019-0331-2
Yang, R., Xu, Y., Dai, Z., Lin, X., and Wang, H. (2018). The immunologic role of gut microbiota in patients with chronic HBV infection. J. Immunol. Res. 2018:2361963. doi: 10.1155/2018/2361963
Yao, B., Cai, Y., Wang, W., Deng, J., Zhao, L., Han, Z., et al. (2023). The effect of gut microbiota on the progression of intervertebral disc degeneration. Orthop. Surg. 15, 858–867.
Yao, W., Mai, X., Luo, C., Ai, F., and Chen, Q. (2011). A cross-sectional survey of nonspecific low back pain among 2083 schoolchildren in China. Spine 36, 1885–1890. doi: 10.1097/BRS.0b013e3181faadea
Yu, M., D’Amelio, P., Tyagi, A. M., Vaccaro, C., Li, J. Y., Hsu, E., et al. (2018). Regulatory T cells are expanded by Teriparatide treatment in humans and mediate intermittent PTH-induced bone anabolism in mice. EMBO Rep. 19, 156–171. doi: 10.15252/embr.201744421
Yuan, X., Chen, B., Duan, Z., Xia, Z., Ding, Y., Chen, T., et al. (2021). Depression and anxiety in patients with active ulcerative colitis: Crosstalk of gut microbiota, metabolomics and proteomics. Gut Microbes 13:1987779. doi: 10.1080/19490976.2021.1987779
Yuan, Y., Zhou, Z., Jiao, Y., Li, C., Zheng, Y., Lin, Y., et al. (2017). Histological identification of propionibacterium acnes in nonpyogenic degenerated intervertebral discs. Biomed. Res. Int. 2017:6192935. doi: 10.1155/2017/6192935
Yurube, T., Buchser, W. J., Moon, H. J., Hartman, R. A., Takayama, K., Kawakami, Y., et al. (2019). Serum and nutrient deprivation increase autophagic flux in intervertebral disc annulus fibrosus cells: An in vitro experimental study. Eur. Spine J. 28, 993–1004. doi: 10.1007/s00586-019-05910-9
Zaiss, M. M., Jones, R. M., Schett, G., and Pacifici, R. (2019). The gut-bone axis: How bacterial metabolites bridge the distance. J. Clin. Invest. 129, 3018–3028. doi: 10.1172/JCI128521
Zhan, J. W., Wang, S. Q., Feng, M. S., Gao, J. H., Wei, X., Yu, J., et al. (2021). Effects of axial compression and distraction on vascular bud and VEGFA expression in the vertebral endplate of an ex vivo rabbit spinal motion segment culture model. Spine 46, 421–432. doi: 10.1097/BRS.0000000000003816
Zhan, J. W., Wang, S. Q., Feng, M. S., Wei, X., Yu, J., Yin, X. L., et al. (2020). Constant compression decreases vascular bud and VEGFA expression in a rabbit vertebral endplate ex vivo culture model. PLoS One 15:e0234747. doi: 10.1371/journal.pone.0234747
Zhang, Y. W., Cao, M. M., Li, Y. J., Dai, G. C., Lu, P. P., Zhang, M., et al. (2023). The regulative effect and repercussion of probiotics and prebiotics on osteoporosis: Involvement of brain-gut-bone axis. Crit. Rev. Food Sci. Nutr. 63, 7510–7528. doi: 10.1080/10408398.2022.2047005
Zhang, Y. W., Cao, M. M., Li, Y. J., Zhang, R. L., Wu, M. T., Yu, Q., et al. (2022). Fecal microbiota transplantation as a promising treatment option for osteoporosis. J. Bone Miner Metab. 40, 874–889.
Zhou, J., Mi, J., Peng, Y., Han, H., and Liu, Z. (2021). Causal associations of obesity with the intervertebral degeneration, low back pain, and sciatica: A two-sample Mendelian randomization study. Front. Endocrinol. 12:740200. doi: 10.3389/fendo.2021.740200
Zhou, Z., Cui, S., Du, J., Richards, R. G., Alini, M., Grad, S., et al. (2021). One strike loading organ culture model to investigate the post-traumatic disc degenerative condition. J. Orthop. Transl. 26, 141–150. doi: 10.1016/j.jot.2020.08.003
Zhu, H., Tian, P., Qian, X., Gu, L., Zhao, J., Wang, G., et al. (2022). Perinatal transmission of a probiotic Bifidobacterium strain protects against early life stress-induced mood and gastrointestinal motility disorders. Food Funct. 13, 7520–7528. doi: 10.1039/d2fo01164f
Zhu, Z., Gu, Y., Zeng, C., Yang, M., Yu, H., Chen, H., et al. (2022). Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis. Front. Pharmacol. 13:897926. doi: 10.3389/fphar.2022.897926
Zhu, J., Liu, S., Zhang, H., Zhao, W., Ding, J., Dai, R., et al. (2023). Dynamic distribution of gut microbiota during Alzheimer’s disease progression in a mice model. Apmis 131, 480–490. doi: 10.1111/apm.13339
Zhu, R., Liu, L., Zhang, G., Dong, J., Ren, Z., and Li, Z. (2023). The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis. Biosci. Rep. 43:BSR20222524.
Zhu, S., Jiang, Y., Xu, K., Cui, M., Ye, W., Zhao, G., et al. (2020). The progress of gut microbiome research related to brain disorders. J. Neuroinflamm. 17:25.
Zou, L., Tian, Y., Wang, Y., Chen, D., Lu, X., Zeng, Z., et al. (2023). High-cholesterol diet promotes depression- and anxiety-like behaviors in mice by impact gut microbe and neuroinflammation. J. Affect. Disord. 327, 425–438. doi: 10.1016/j.jad.2023.01.122
Zou, X., Zhang, X., Han, S., Wei, L., Zheng, Z., Wang, Y., et al. (2023). Pathogenesis and therapeutic implications of matrix metalloproteinases in intervertebral disc degeneration: A comprehensive review. Biochimie 214, 27–48.
Zou, X., Wang, L., Xiao, L., Wang, S., and Zhang, L. (2022). Gut microbes in cerebrovascular diseases: Gut flora imbalance, potential impact mechanisms and promising treatment strategies. Front. Immunol. 13:975921. doi: 10.3389/fimmu.2022.975921
Zucoloto, A. Z., Schlechte, J., Ignacio, A., Thomson, C. A., Pyke, S. I, Yu, L., et al. (2023). Vascular traffic control of neutrophil recruitment to the liver by microbiota-endothelium crosstalk. Cell Rep. 42:112507. doi: 10.1016/j.celrep.2023.112507
Keywords: gut microbes, intervertebral disk degeneration, low back pain, spine, inflammatory, gut-disk axis
Citation: Wang K, Liu X, Huang H, Suo M, Wang J, Liu X, Zhang J, Chen X and Li Z (2024) A new target for treating intervertebral disk degeneration: gut microbes. Front. Microbiol. 15:1452774. doi: 10.3389/fmicb.2024.1452774
Received: 21 June 2024; Accepted: 16 September 2024;
Published: 29 November 2024.
Edited by:
Mingsong Kang, Canadian Food Inspection Agency (CFIA), CanadaReviewed by:
Benjamin Gantenbein, University of Bern, SwitzerlandBo Gao, Air Force Military Medical University, China
Copyright © 2024 Wang, Liu, Huang, Suo, Wang, Liu, Zhang, Chen and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zhonghai Li, bGl6aG9uZ2hhaXNwaW5lQDEyNi5jb20=